Pirtobrutinib - Loxo Oncology
At a glance
- Drug Originator Redx Pharma
- Drug Licenced by Innovent Biologics; Nippon Shinyaku
- Drug Class Amides; Amines; Antineoplastics; Fluorobenzenes; Pyrazoles; Small molecules
- Mechanism of Action Agammaglobulinaemia tyrosine kinase inhibitors
- USA Patent Applicants LOXO ONCOL
- USA Patents 8
- NDAs 1
- International Patents 97
- Patent Applications 12
Table of Contents
Disclaimer